The French National Pharmaceutical Academy estimates that the EU imports 80 percent of its 'active pharmaceutical ingredients' - mostly from China and India (Photo: Grumpy-Puddin)

Will coronavirus change EU's pharma supply chain?

Digital

Health & Society

by Elena Sánchez Nicolás, Brussels,

The impact of the coronavirus on China and India, two of the world's largest pharmaceutical exporters, has disrupted medicine supply chains worldwide, seeing manufacturing, distribution and trade restrictions, plus short-term scarcities for certain products.

"This crisis has revealed our morbid dependency on China and India as regards pharmaceuticals," the European Commission vice-president Vera Jourova said on Sunday (April 19) in a debate on Czech state television.

"This is some...

Get EU news that matters

Back our independent journalism by becoming a supporting member

Already a member? Login here

Digital Health & Society

Author Bio

Elena is EUobserver's Managing Editor. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.

Von der Leyen: new budget will be EU's corona response

Saving Europe from corona's nasty geopolitics

The plight of Europe's disabled under coronavirus

It doesn't have to be coronavirus 'or' Green Deal

The French National Pharmaceutical Academy estimates that the EU imports 80 percent of its 'active pharmaceutical ingredients' - mostly from China and India (Photo: Grumpy-Puddin)